Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank57
3Y CAGR-1.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-1.8%/yr
Annual compound
Percentile
P57
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.82M | -51.3% |
| 2024 | $16.06M | +17.2% |
| 2023 | $13.71M | +66.0% |
| 2022 | $8.26M | +1508.7% |
| 2021 | $-586000.00 | -117.8% |
| 2020 | $-269000.00 | -511.4% |
| 2019 | $-44000.00 | +84.7% |
| 2018 | $-288000.00 | - |